CMPDI is a wholly-owned mine planning and consultancy subsidiary of Maharatna PSU Coal India Limited (CIL).
In the two sessions, post announcement of its Q1 results on Saturday (July 18), HDFC Bank shares have lost nearly 7 per cent. The sharp decline has erased around ₹80,000 crore from its market cap.
In the recently concluded June 2026 quarter, domestic mutual funds reduced their stake in MTAR Technologies to 20.36 per cent from 23.49 per cent at the end of March 2026 quarter.
Post Q1 results, JM Financial has upgraded YES Bank to 'Reduce' from 'Sell', citing a gradual improvement in underlying fundamentals.
Tatva Chintan Pharma: The stock price of the specialty chemicals hit a 52-week high of ₹1,714.10, and rallied 43% thus far in July.
According to NSE data, several institutional investors bought shares of Laser Power & Infra through open-market transactions after its listing on Thursday.
Today's rally came after Abakkus Investment Managers Pvt Ltd, owned by ace investor Sunil Singhania, acquired 29,39,588 shares of Mrs Bectors Food Specialities through a bulk deal.
As per NSE data, MRPL shares have outperformed the Nifty 50 index over the past year, having gained 19.24 per cent.
J&K Bank has proposed to divest 10.25 million equity shares in PNB MetLife India Insurance Company at ₹117.20 apiece, taking the transaction value to ₹120.1 crore.
According to the shareholding data, ace investor Mukul Agrawal held 1.45 equity stake in Hind Rectifiers as of March 2026.
Fino Payments Bank share price jumped 13 per cent on Monday after the company announced its business performance for June.
As per reports, Voltas has increased prices across the RAC portfolio by 2.5 per cent to 3 per cent.
Dixon Technologies today was up 4 per cent intraday as the company secured government approval to set up its joint venture (JV) with Vivo Mobile India (VMI).
Apollo Micro shares gained 5 per cent after approval was granted to the company to acquire 41.3 per cent stake in Premier Explosives.
Nomura has maintained a 'Buy' rating on Indus Towers. The brokerage has kept its target price unchanged at ₹505, implying an upside of 30 per cent from its previous close of ₹388.55.
Piramal Pharma said that the US FDA has issued an Establishment Inspection Report (EIR) for its Sellersville facility, and the inspection has now been successfully closed.
Natco Pharma has announced investments of nearly ₹2,500 crore in South Africa, including infusing ₹1,400 crore in its arm in the country with an aim to enter new geographies.
RCF has informed that its board has approved plans to raise funds by way of a "Further Public Offering through a fresh issue of equity shares by the company aggregating up to ₹1,500 crore".
Supriya Lifescience said proceedings were initiated against the personnel of the company under the NDPS Act, 1985 for a procedural lapse for a single export transaction of an identified producer.
Jagsonpal Pharmaceuticals has entered into a definitive agreement to acquire an 85 per cent equity stake in Aequitas Healthcare